16 May 2019

EUCAST hopes to add one more PK-PD expert to the Steering Committee.

Due to the increasing number of proposals of new antimicrobials requesting marketing authorisation and the increasing pace of reviewing existing breakpoints, the EUCAST Steering Committee is seeking to expand its expertise in pharmacokinetics-pharmacodynamics as it relates to susceptibility testing and clinical breakpoint setting. We are looking for a colleague with expertise in PK-PD and a general understanding of clinical infection and antibacterial therapeutics. Interested colleagues should address this no later than 30 June, 2019.